Drug coated balloons and their role in bifurcation coronary angioplasty: appraisal of the current evidence and future directions

References

• Elwany M, Di Palma G, Cortese B. Treatment of coronary bifurcation lesions: current knowledge and future perspectives. Future Cardiol. 2018;14:165–179.
   PubMed Web of Science ®Google Scholar
• Lassen JF, Holm NR, Stankovic G, et al. Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10 years of the European Bifurcation Club meetings. EuroIntervention. 2014;10(5):545–560.
   Web of Science ®Google Scholar
• Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation. 2004;109(10):1244–1249.
   Web of Science ®Google Scholar
• Hoye A, Iakovou I, Ge L, et al. Long-term outcomes after stenting of bifurcation lesions with the “Crush” technique. Predictors of an adverse outcome. J Am Coll Cardiol. 2006;47:1949–1958.
   PubMed Web of Science ®Google Scholar
• Hassan AKM, Bergheanu SC, Stijnen T, et al. Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J. 2010;31(10):1172–1180.
   PubMed Web of Science ®Google Scholar
• Nakazawa G, Yazdani SK, Finn AV, et al. Pathological findings at bifurcation lesions. the impact of flow distribution on atherosclerosis and arterial healing after stent implantation. J Am Coll Cardiol. 2010. DOI:10.1016/j.jacc.2010.01.021
   PubMed Web of Science ®Google Scholar
• Niccoli G, Ferrante G, Porto I, et al. Coronary bifurcation lesions: to stent one branch or both? A meta-analysis of patients treated with drug eluting stents. Int J Cardiol. 2010;139(1):80–91.
   PubMed Web of Science ®Google Scholar
• Cortese B, Piraino D, Buccheri D, et al. Treatment of bifurcation lesions with drug-coated balloons: A review of currently available scientific data. Int J Cardiol. 2016;220:589–594.
   PubMed Web of Science ®Google Scholar
• Gao XF, Zhang YJ, Tian NL, et al. Stenting strategy for coronary artery bifurcation with drug-eluting stents: A meta-analysis of nine randomised trials and systematic review. EuroIntervention. 2014;10:561–569.
   Web of Science ®Google Scholar
• Iakovou I, Kadota K, Papamentzelopoulos S, et al. Is there a higher risk of stent thrombosis in bifurcation lesions, or is this related to the technique? EuroIntervention. 2010;6 Suppl J:J 107-11.
   Web of Science ®Google Scholar
• Siontis GCM, Piccolo R, Praz F, et al. Percutaneous coronary interventions for the treatment of stenoses in small coronary arteries: a network meta-analysis. JACC Cardiovasc Interv. 2016;9:1324–1334.
   Web of Science ®Google Scholar
• Jeger R, Pfsterer M, Pfster O, et al. First-generation paclitaxel- vs. second-generation zotarolimus-eluting stents in small coronary arteries: the BASKET-SMALL Pilot Study. Postep W Kardiol Interwencyjnej. 2016. DOI:10.5114/aic.2016.63630
   PubMed Web of Science ®Google Scholar
• Banning AP, Lassen JF, Burzotta F, et al. Percutaneous coronary intervention for obstructive bifurcation lesions: the 14th consensus document from the European Bifurcation Club. EuroIntervention. 2019;15(1):90–98.
   Web of Science ®Google Scholar
• Nasu K, Oikawa Y, Yoshikawa R, et al. A randomized comparison of sirolimus- vs. paclitaxel-eluting stents for treatment of bifurcation lesions by single stent and kissing balloon: results of the SINGLE KISS trial. Int J Cardiol. 2013;166(1):187–192.
   PubMed Web of Science ®Google Scholar
• Rittger H, Brachmann J, Sinha AM, et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol. 2012;59:1377–1382.
   PubMed Web of Science ®Google Scholar
• Latib A, Colombo A, Castriota F, et al. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the bello (balloon elution and late loss optimization) study. J Am Coll Cardiol. 2012;60(24):2473–2480.
   Web of Science ®Google Scholar
• Collet C, Mizukami T, Grundeken MJ. Contemporary techniques in percutaneous coronary intervention for bifurcation lesions. Expert Rev Cardiovasc Ther. 2018;16(10):725–734.
   PubMed Web of Science ®Google Scholar
• Chen SL, Santoso T, Zhang JJ, et al. A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions. J Am Coll Cardiol. 2011. DOI:10.1016/j.jacc.2010.10.023
   Web of Science ®Google Scholar
• Steigen TK, Maeng M, Wiseth R, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the nordic bifurcation study. Circulation. 2006;114(18):1955–1961.
   PubMed Web of Science ®Google Scholar
• Hildick-Smith D, De Belder AJ, Cooter N, et al. Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies. Circulation. 2010;121(10):1235-1243.
   PubMed Web of Science ®Google Scholar
• Bavry A. Randomized comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch - nordic-baltic bifurcation Study IV. San Francisco; 2013.
   Google Scholar
• Maeng M, Holm NR, Erglis A, et al. Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: nordic bifurcation study 5-year follow-up results. J Am Coll Cardiol. 2013;62(1):30–34.
   PubMed Web of Science ®Google Scholar
• Behan MW, Holm NR, De Belder AJ, et al. Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study. Eur Heart J. 2016;37(24):1923–1928.
   PubMed Web of Science ®Google Scholar
• Hildick-Smith D, Behan MW, Lassen JF, et al. The EBC TWO Study (European Bifurcation Coronary TWO). Circ Cardiovasc Interv. 2016;9(9). DOI:10.1161/circinterventions.115.003643
   PubMed Web of Science ®Google Scholar
• Zimarino M, Corazzini A, Ricci F, et al. Late thrombosis after double versus single drug-eluting stent in the treatment of coronary bifurcations: a meta-analysis of randomized and observational Studies. JACC Cardiovasc Interv. 2013;6(7):687–695.
   PubMed Web of Science ®Google Scholar
• Hildick-Smith D, Lassen JF, Albiero R, et al. Consensus from the 5th European Bifurcation Club meeting. EuroIntervention. 2010;6(1):34–38.
   Web of Science ®Google Scholar
• Serruys PW, Garcia-Garcia HM, Onuma Y. From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J. 2012;33:16–25.
   Web of Science ®Google Scholar
• Loh JP, Waksman R. Paclitaxel drug-coated balloons: A review of current status and emerging applications in native coronary artery de novo lesions. JACC Cardiovasc Interv. 2012;5(10):1001–1012.
   PubMed Web of Science ®Google Scholar
• Kleber FX, Mathey DG, Rittger H, et al. How to use the drug-eluting balloon: recommendations by the German consensus group. EuroIntervention. 2011;7(K):K125-K128.
   PubMed Web of Science ®Google Scholar
• Turner EA, Atigh MK, Erwin MM, et al. Coating and Pharmacokinetic evaluation of air spray coated drug coated balloons. Cardiovasc Eng Technol. 2018;9:240–250.
   PubMed Web of Science ®Google Scholar
• Scheller B, Speck U, Abramjuk C, et al. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004;110:810–814.
   PubMed Web of Science ®Google Scholar
• Cramers B, Speck U, Kaufels N, et al. Drug-eluting balloon: very short-term exposure and overlapping. Thromb Haemost. 2009. DOI:10.1160/TH08-06-0387
   Web of Science ®Google Scholar
• Heilmann T, Richter C, Noack H, et al. Drug release profiles of different drug-coated balloon platforms. Eur Cardiol Rev. 2010. DOI:10.15420/ecr.2010.8.2.40
   Google Scholar
• Scheller B, Fontaine T, Mangner N, et al. A novel drug coated balloon for the treatment of coronary In stent-restenosis: results for the multicenter randomised controlled PATENT-C first in human trial. Catheter Cardiovas Interv. 2016. DOI:10:1002/ccd.26216
   Google Scholar
• Palma G, Cortese B. Novel Paclitaxel- coated Scoring balloon for de novo complex coronary lesions: first report. Cardiovasc Revasc Med. 2018. DOI:10.1016/j.carrev:2017
   Web of Science ®Google Scholar
• Jeger RV, Farah A, Ohlow MA, et al. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet. 2018;392:849–856.
   PubMed Web of Science ®Google Scholar
• Cortese B, Micheli A, Picchi A, et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart. 2010;96(16):1291–1296.
   Web of Science ®Google Scholar
• Bondesson P, Lagerqvist B, James SK, et al. Comparison of two drug-eluting balloons: A report from the SCAAR registry. EuroIntervention. 2012;8(4):444–449.
   PubMed Web of Science ®Google Scholar
• Nikol S, Huehns TY, Höfling B. Molecular biology and post-angioplasty restenosis. Atherosclerosis. 1996;123(1–2):17–31.
   PubMed Web of Science ®Google Scholar
• Granada JF, Stenoien M, Buszman PP, et al. Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing. Open Heart. 2014;1(1):e000117.
   PubMedGoogle Scholar
• Nakano YV. No title the present state of drug-coated balloons. Cardiology Today’s Interv.
   Google Scholar
• Bruch L, Zadura M, Waliszewski M, et al. Results from the international drug coated balloon registry for the treatment of bifurcations. can a bifurcation be treated without stents? J Interv Cardiol. 2016;29(4):348–356.
   PubMed Web of Science ®Google Scholar
• Jim MH, Lee MKY, Fung RCY, et al. Six month angiographic result of supplementary paclitaxel-eluting balloon deployment to treat side branch ostium narrowing (SARPEDON). Int J Cardiol. 2015;187:594–597.
   PubMed Web of Science ®Google Scholar
• Katsanos K, Spillopoulos S, Kitrou P, et al. Risk of death following application of paclitaxel‐coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta‐analysis of randomized controlled trials. J Am Heart Ass. 2018 Dec 6 . DOI:10.1161/JAHA.118.011245.
   Google Scholar
• Scheller B, Vukadinivic D, Jeger R, et al. Survival After Coronary Revascularization with Paclitaxel-Coated Balloons. J Am Coll Cardiol. 2020 March 10;75(9):1017–1028.
   PubMed Web of Science ®Google Scholar
• Mathey DG, Wendig I, Boxberger M, et al. Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial. EuroIntervention. 2011;7(K):K61-K65.
   PubMed Web of Science ®Google Scholar
• Kleber FX, Rittger H, Ludwig J, et al. Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial. Clin Res Cardiol. 2016;105(7):613–621.
   PubMed Web of Science ®Google Scholar
• Herrador JA, Fernandez JC, Guzman M, et al. Drug-eluting vs. conventional balloon for side branch dilation in coronary bifurcations treated by provisional T stenting. J Interv Cardiol. 2013;26(5):454–462.
   PubMed Web of Science ®Google Scholar
• Yerasi C, Case BC, Forrestal BJ, et al. Drug- Coated balloon for de novo coronary artery disease. State of the art review. J Amer Coll Cardiol. 2020;75:1061–1073.
   PubMed Web of Science ®Google Scholar
• Clever YP, Peters D, Calisse J, et al. Novel sirolimus-coated balloon catheter: in vivo evaluation in a porcine coronary model. Circ Cardiovasc Interv. 2016;9(4). DOI:10.1161/CIRCINTERVENTIONS.115.003543
   PubMed Web of Science ®Google Scholar
• Cortese B, Di Palma G, Latini RA, et al. Immediate and short-term performance of a novel sirolimus-coated balloon during complex percutaneous coronary interventions. The FAtebenefratelli SIrolimus COated-balloon (FASICO) registry. Cardiovasc Revascularization Med. 2017;18(7):487–491.
   PubMed Web of Science ®Google Scholar
• Cortese B Proccedings during EURO PCR 2019 Scientific sessions.
   Google Scholar
• Ali RM, Kadre MA, Ahmad WA, et al. Treatment of coronary drug-eluting stent restenosis with sirolimus or paclitaxel coated balloon. JACC Cardiovasc Interv. 2019. DOI:10.1016/j.jcin.2018.11.040
   Web of Science ®Google Scholar
• Nugyen VT, Kim C, Hong SJ, et al. Comparison of two different tyoes of Paclitaxel coated balloons for treatment of patients with Coronary In-Stent Restenosis. Heart Vessels. 2019. DOI:10.1007/s00380-019-01388-z
   Web of Science ®Google Scholar
• Chen Y, Gao L, Chen S, et al. Comparison of 2-Different drug-coated balloons in in-stent restenosis: the RESTORE CHINA ISR Randomized trial. JACC Cardiovasc Interv. 2018. DOI:10.1016/j.jcin.2018.09.010
   Web of Science ®Google Scholar
• Tanaka A, Latib A, Jabbour RJ, et al. Impact of Angiographic result after pre-dilatation on outcome after drug coated balloon treatment of coronary in stent restenosis. Am J Cardiol. 2016. DOI:10.1016/j.amjcard.2016.08.016
   Web of Science ®Google Scholar
• Cortes B, Silva P, Agostoni P, et al. Effect of Drug- Coated Balloonsin native coronary artery diseaseleft with a dissection. JACC Cardiovasc Interv. 2015. DOI:10.1016/j.jcin.2015.08.029
   Web of Science ®Google Scholar
• Jeger RV, Farah A, Ohlow MA, et al. Drug-Coated balloon for small coronary arteri disease (BASKET- SMALL 2): an Open-lapel Randomozed non- inferiority trial. Lancet. 2018;6736(18): 31719–7.
   Google Scholar
• Schulz A, Hauschild T, Kleber FX. Treatment of coronary de novo bifurcation lesions with DCB only strategy. Clin Res Cardiol. 2014;103(6):451–456.
   Web of Science ®Google Scholar
• Stella PR, Belkacemi A, Dubois C, et al. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of th. Catheter Cardiovasc Interv. 2012;80(7):1138–1146.
   Web of Science ®Google Scholar
• Sgueglia GA, Todaro D, Bisciglia A, et al. Kissing inflation is feasible with all second-generation drug-eluting balloons. Cardiovasc Revascularization Med. 2011;12(5):280–285.
   PubMedGoogle Scholar
• Mínguez JRL, Asensio JMN, Vecino LJD, et al. A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (babilon trial): 24-month clinical and angiographic results. EuroIntervention. 2014. DOI:10.4244/EIJV10I1A10
   Web of Science ®Google Scholar
• Megaly M, Rofael M, Saad M, et al. Outcomes with drug-coated balloons for treating the side branch of coronary bifurcation lesions. J Invasive Cardiol. 2018;30(11):393-399.
   Web of Science ®Google Scholar
• Harada Y, Pinieck S, Colleran R, et al. Angiographic and clinical outcomes of patients treated with Drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a two-stent technique. Eurointervention. 2017;12:2132–2139.
   PubMed Web of Science ®Google Scholar
• Lee WC, Hsueh HK, Chen CJ, et al. The comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for left main stem in-stent restenosis. Int Hear J. 2018. DOI:10.1536/ihj.17-540
   Web of Science ®Google Scholar
• Naganuma T, Latib A, Costopoulos C, et al. Drug-eluting balloon versus second-generation drug-eluting stent for the treatment of restenotic lesions involving coronary bifurcations. EuroIntervention. 2016;11:989–995.
   PubMed Web of Science ®Google Scholar
• Habara S, Kadota K, Kanazawa T, et al. Paclitaxel-coated balloon catheter compared with drug-eluting stent for drug-eluting stent restenosis in routine clinical practice. EuroIntervention. 2016;11:1098–1105.
   PubMed Web of Science ®Google Scholar
• Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, et al. RIBS IV Study Investigators (under auspices of Interventional Cardiology Working Group of Spanish Society of Cardiology). A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the ribs iv randomized clinical trial. J Am Coll Cardiol. 2015;66:23–33.
   PubMed Web of Science ®Google Scholar
• Habara S, Mitsudo K, Kadota K, et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv. 2011;4:149–154.
   PubMed Web of Science ®Google Scholar
• Byrne RA, Neumann FJ, Mehilli J, et al. ISAR-DESIRE 3 investigators. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet. 2013;381:461–467.
   PubMed Web of Science ®Google Scholar
• Xu B, Gao R, Wang J, et al. PEPCAD China ISR Trial Investigators. A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial. JACC Cardiovasc Interv. 2014;7:204–211.
   PubMed Web of Science ®Google Scholar
• Joner M, Byrne RA, Lapointe JM, et al. Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis. Thromb Haemost. 2011. DOI:10.1160/TH-10-11-0698
   PubMed Web of Science ®Google Scholar
• Cortese B, Berti S, Biondi-Zoccai G, et al., Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology. Catheter Cardiovasc Interv. 2014;83(3):427–435.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang J, Liu B, et al. China expert consensus on clinical application of the drug coated balloon. Cardiol Plus. 2016;1:41–48.
   Google Scholar
• Alfonso F, Scheller B. State of the art: balloon catheter technologies – drug-coated balloon. EuroIntervention. 2017;13(6):680–695.
   Web of Science ®Google Scholar
• Nestelberger T, Kaiser C, Jeger R. Drug-coated balloons in cardiovascular disease: benefits, challenges, and clinical applications. Expert Opin Drug Deliv. 2020;17(2):201-211.
   PubMed Web of Science ®Google Scholar